All terms in GO
| Label | Id | Description |
|---|---|---|
| medium-chain fatty-acyl-CoA metabolic process | GO_0036112 |
The chemical reactions and pathways involving medium-chain fatty-acyl-CoAs, any derivative of coenzyme A in which the sulfhydryl group is in a thioester linkage with a long-chain fatty-acyl group. A medium-chain fatty acid is a fatty acid with a chain length of between C6 and C12.
|
| very long-chain fatty-acyl-CoA catabolic process | GO_0036113 |
The chemical reactions and pathways resulting in the breakdown of very long-chain fatty-acyl-CoAs, any derivative of coenzyme A in which the sulfhydryl group is in a thioester linkage with a medium-chain fatty-acyl group. A very long-chain fatty acid is a fatty acid which has a chain length greater than C22.
|
| very long-chain fatty-acyl-CoA metabolic process | GO_0036111 |
The chemical reactions and pathways involving very long-chain fatty-acyl-CoAs, any derivative of coenzyme A in which the sulfhydryl group is in a thioester linkage with a medium-chain fatty-acyl group. A very long-chain fatty acid is a fatty acid which has a chain length greater than C22.
|
| negative regulation of TORC2 signaling | GO_1903940 |
Any process that stops, prevents or reduces the frequency, rate or extent of TORC2 signaling.
|
| response to platelet-derived growth factor | GO_0036119 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus.
|
| positive regulation of respiratory gaseous exchange | GO_1903942 |
Any process that activates or increases the frequency, rate or extent of respiratory gaseous exchange.
|
| hyaluranon cable assembly | GO_0036118 |
A process that results in the aggregation, arrangement and bonding together of a hyaluranon cable, a cable structure, surrounding some cell types (e.g. proximal or bronchial tubular epithelial cells), and composed of hyaluranon (HA), a ubiquitous connective tissue glycosaminoglycan.
|
| negative regulation of respiratory gaseous exchange | GO_1903941 |
Any process that stops, prevents or reduces the frequency, rate or extent of respiratory gaseous exchange.
|
| hyaluranon cable | GO_0036117 |
A cable structure, surrounding some cell types (e.g. proximal or bronchial tubular epithelial cells), and composed of hyaluranon (HA), a ubiquitous connective tissue glycosaminoglycan.
|
| negative regulation of hepatocyte apoptotic process | GO_1903944 |
Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte apoptotic process.
|
| regulation of hepatocyte apoptotic process | GO_1903943 |
Any process that modulates the frequency, rate or extent of hepatocyte apoptotic process.
|
| long-chain fatty-acyl-CoA catabolic process | GO_0036116 |
The chemical reactions and pathways resulting in the breakdown of long-chain fatty-acyl-CoAs, any derivative of coenzyme A in which the sulfhydryl group is in a thioester linkage with a medium-chain fatty-acyl group. A long-chain fatty acid is a fatty acid with a chain length between C13 and C22.
|
| negative regulation of ventricular cardiac muscle cell action potential | GO_1903946 |
Any process that stops, prevents or reduces the frequency, rate or extent of ventricular cardiac muscle cell action potential.
|
| negative regulation of cardiac muscle cell contraction | GO_0106135 |
Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle cell contraction.
|
| GO_0002818 | GO_0002818 | |
| positive regulation of hepatocyte apoptotic process | GO_1903945 |
Any process that activates or increases the frequency, rate or extent of hepatocyte apoptotic process.
|
| negative regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | GO_0002817 |
Any process that stops, prevents, or reduces the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.
|
| negative regulation of antibacterial peptide biosynthetic process | GO_0002809 |
Any process that stops, prevents, or reduces the frequency, rate, or extent of antibacterial peptide biosynthesis.
|
| regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | GO_0002816 |
Any process that modulates the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.
|
| negative regulation of atrial cardiac muscle cell action potential | GO_1903948 |
Any process that stops, prevents or reduces the frequency, rate or extent of atrial cardiac muscle cell action potential.
|